1. (a) Subject to subsection (b), the office may place limits on quantities dispensed or the frequency of refills for any covered drug as required by law or for the purpose of:

   1. (1) preventing fraud, abuse, or waste;

   2. (2) preventing overutilization, inappropriate utilization, or inappropriate prescription practices that are contrary to:

      1. (A) clinical quality and patient safety; and
      2. (B) accepted clinical practice for the diagnosis and treatment of mental illness and the considerations specified in subsection (h); or
   3. (3) implementing a disease management program.

2. (b) Before implementing a limit described in subsection (a), the office shall:

   1. (1) consider quality of care and the best interests of Medicaid recipients;
   2. (2) seek the advice of the drug utilization review board, established by IC 12-15-35-19 , at a public meeting of the board; and
   3. (3) publish a provider bulletin that complies with the requirements of IC 12-15-13-6 .

As added by P.L.6-2002, SEC.4. Amended by P.L.184-2003, SEC.11; P.L.101-2005, SEC.7; P.L.8-2007, SEC.1; P.L.36-2009, SEC.3; P.L.229-2011, SEC.145; P.L.7-2015, SEC.35; P.L.210-2015, SEC.51; P.L.213-2025, SEC.118.